statement_id,standardized_cancer,raw_cancer,biomarker,therapy,modified_standard_cancer
0,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['T315I'],['Ponatinib'],B-Lymphoblastic Leukemia/Lymphoma
1,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Ponatinib'],Chronic Myelogenous Leukemia
2,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Asciminib'],Chronic Myelogenous Leukemia
3,Breast Cancer,Breast Cancer,['E17K'],"['Capivasertib,Fulvestrant']",Breast Cancer
4,Melanoma,Melanoma,['V600E'],['Dabrafenib'],Melanoma
5,All Solid Tumors,All Solid Tumors,['V600E'],"['Dabrafenib,Trametinib']",All Solid Tumors
6,Anaplastic Thyroid Cancer,Anaplastic Thyroid Cancer,['V600E'],"['Dabrafenib,Trametinib']",Anaplastic Thyroid Cancer
7,Hepatobiliary Cancer,Hepatobiliary Cancer,['V600E'],"['Dabrafenib,Trametinib']",Hepatobiliary Cancer
8,Biliary Tract,Biliary Tract,['V600E'],"['Dabrafenib,Trametinib']",Biliary Tract
9,"Low-Grade Glioma, NOS","Low-Grade Glioma, NOS",['V600E'],"['Dabrafenib,Trametinib']","Low-Grade Glioma, NOS"
10,Melanoma,Melanoma,"['V600E,V600K']","['Dabrafenib,Trametinib']",Melanoma
11,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['V600E'],"['Dabrafenib,Trametinib']",Non-Small Cell Lung Cancer
12,Colorectal Cancer,Colorectal Cancer,['V600E'],"['Encorafenib,Cetuximab']",Colorectal Cancer
13,Colorectal Cancer,Colorectal Cancer,['V600E'],"['Encorafenib,Cetuximab,FOLFOX Regimen']",Colorectal Cancer
14,"Low-Grade Glioma, NOS","Low-Grade Glioma, NOS",['V600'],['Tovorafenib'],"Low-Grade Glioma, NOS"
15,Erdheim-Chester Disease,Erdheim-Chester Disease,['V600'],['Vemurafenib'],Erdheim-Chester Disease
16,Melanoma,Melanoma,['V600'],"['Vemurafenib,Atezolizumab,Cobimetinib']",Melanoma
17,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['V600E'],"['Encorafenib,Binimetinib']",Non-Small Cell Lung Cancer
18,Melanoma,Melanoma,"['V600E,V600K']",['Trametinib'],Melanoma
19,Melanoma,Melanoma,['V600E'],['Vemurafenib'],Melanoma
20,Melanoma,Melanoma,"['V600E,V600K']","['Vemurafenib,Cobimetinib']",Melanoma
21,Melanoma,Melanoma,"['V600E,V600K']","['Encorafenib,Binimetinib']",Melanoma
22,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Datopotamab Deruxtecan'],Non-Small Cell Lung Cancer
23,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']",['Erlotinib'],Non-Small Cell Lung Cancer
24,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']","['Osimertinib,Chemotherapy']",Non-Small Cell Lung Cancer
25,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']","['Amivantamab,Chemotherapy']",Non-Small Cell Lung Cancer
26,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']","['Erlotinib,Ramucirumab']",Non-Small Cell Lung Cancer
27,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']",['Afatinib'],Non-Small Cell Lung Cancer
28,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']","['Amivantamab,Lazertinib']",Non-Small Cell Lung Cancer
29,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']",['Gefitinib'],Non-Small Cell Lung Cancer
30,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']",['Osimertinib'],Non-Small Cell Lung Cancer
31,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 19 in-frame deletions,L858R']",['Dacomitinib'],Non-Small Cell Lung Cancer
32,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],['Afatinib'],Non-Small Cell Lung Cancer
33,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Exon 20 in-frame insertions'],['Amivantamab'],Non-Small Cell Lung Cancer
34,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Exon 20 in-frame insertions'],['Sunvozertinib'],Non-Small Cell Lung Cancer
35,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Exon 20 in-frame insertions'],"['Amivantamab,Chemotherapy']",Non-Small Cell Lung Cancer
36,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],['Afatinib'],Non-Small Cell Lung Cancer
37,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['T790M'],['Osimertinib'],Non-Small Cell Lung Cancer
38,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],['Afatinib'],Non-Small Cell Lung Cancer
39,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['G776V,L841V,T798M,D821N,L755W,V842I,A710V,V697L,L755A,G776S,L869R,E717D,L866M,G815R,Q709L,V794M,D808N,Exon 20 in-frame insertions,V777M,L768S,V773L,L726F,L726I,T733I,L755P,L755S,I767M,D769H,D769Y,V777L']",['Zongertinib'],Non-Small Cell Lung Cancer
40,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Trastuzumab Deruxtecan'],Non-Small Cell Lung Cancer
41,Breast Cancer,Breast Cancer,"['E380,S463P,Y537,L536,L469V,D538']",['Elacestrant'],Breast Cancer
42,Follicular Lymphoma,Follicular Lymphoma,"['A692V,Y646H,Y646S,Y646C,Y646F,Y646N,A682G']",['Tazemetostat'],Follicular Lymphoma
43,Bladder Cancer,Bladder Cancer,"['R248C,S249C,Y373C,G370C']",['Erdafitinib'],Bladder Cancer
44,Acute Myeloid Leukemia,Acute Myeloid Leukemia,"['R132S,R132L,R132C,R132H,R132G']",['Ivosidenib'],Acute Myeloid Leukemia
45,Intrahepatic Cholangiocarcinoma,Intrahepatic Cholangiocarcinoma,"['R132S,R132L,R132C,R132H,R132G']",['Ivosidenib'],Intrahepatic Cholangiocarcinoma
46,Cholangiocarcinoma,Cholangiocarcinoma,"['R132S,R132L,R132C,R132H,R132G']",['Ivosidenib'],Cholangiocarcinoma
47,Myelodysplastic Syndromes,Myelodysplastic Syndromes,"['R132S,R132L,R132C,R132H,R132G']",['Ivosidenib'],Myelodysplastic Syndromes
48,Oligodendroglioma,Oligodendroglioma,"['R132S,R132L,R132C,R132H,R132G']",['Vorasidenib'],Oligodendroglioma
49,Astrocytoma,Astrocytoma,"['R132S,R132L,R132C,R132H,R132G']",['Vorasidenib'],Astrocytoma
50,Acute Myeloid Leukemia,Acute Myeloid Leukemia,"['R132S,R132L,R132C,R132H,R132G']",['Olutasidenib'],Acute Myeloid Leukemia
51,Acute Myeloid Leukemia,Acute Myeloid Leukemia,"['R172K,R172M,R172S,R140L,R140G,R140W,R172W,R140Q,R172G']",['Enasidenib'],Acute Myeloid Leukemia
52,Oligodendroglioma,Oligodendroglioma,"['R172K,R172M,R172S,R172W,R172G']",['Vorasidenib'],Oligodendroglioma
53,Astrocytoma,Astrocytoma,"['R172K,R172M,R172S,R172W,R172G']",['Vorasidenib'],Astrocytoma
54,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Imatinib'],Gastrointestinal Stromal Tumor
55,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Sunitinib'],Gastrointestinal Stromal Tumor
56,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Regorafenib'],Gastrointestinal Stromal Tumor
57,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Ripretinib'],Gastrointestinal Stromal Tumor
58,Mastocytosis,Mastocytosis,['D816'],['Avapritinib'],Mastocytosis
59,Low-Grade Serous Ovarian Cancer,Low-Grade Serous Ovarian Cancer,['Oncogenic Mutations'],"['Avutometinib,Defactinib']",Low-Grade Serous Ovarian Cancer
60,Colorectal Cancer,Colorectal Cancer,['G12C'],"['Adagrasib,Cetuximab']",Colorectal Cancer
61,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G12C'],['Sotorasib'],Non-Small Cell Lung Cancer
62,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G12C'],['Adagrasib'],Non-Small Cell Lung Cancer
63,Colorectal Cancer,Colorectal Cancer,['G12C'],"['Sotorasib,Panitumumab']",Colorectal Cancer
64,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 14 in-frame deletions,Exon 14 Deletion,D1010,Exon 14 splice mutations']",['Capmatinib'],Non-Small Cell Lung Cancer
65,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 14 in-frame deletions,Exon 14 Deletion,D1010,Exon 14 splice mutations']",['Tepotinib'],Non-Small Cell Lung Cancer
66,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,"['Exon 18 missense mutations,Exon 18 in-frame deletions,Exon 18 in-frame insertions']",['Avapritinib'],Gastrointestinal Stromal Tumor
67,Breast Cancer,Breast Cancer,"['N345K,E545Q,Q546K,Q546P,M1043V,M1043I,G1049R,R88Q']","['Capivasertib,Fulvestrant']",Breast Cancer
68,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],"['Inavolisib,Palbociclib,Fulvestrant']",Breast Cancer
69,Breast Cancer,Breast Cancer,"['C420R,E542K,E545A,E545D,E545G,E545K,Q546E,Q546R,H1047L,H1047R,H1047Y']","['Alpelisib,Fulvestrant']",Breast Cancer
70,Breast Cancer,Breast Cancer,"['C420R,E542K,E545A,E545D,E545G,E545K,Q546E,Q546R,H1047L,H1047R,H1047Y']","['Capivasertib,Fulvestrant']",Breast Cancer
71,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['V299L,F317L,F317I,F317C,T315A,F317V']",['Nilotinib'],B-Lymphoblastic Leukemia/Lymphoma
72,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['V299L,F317L,F317I,F317C,T315A,F317V']",['Nilotinib'],Chronic Myelogenous Leukemia
73,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['Y253H,F359V,F359C,F317I,F317C,F359I,T315A,F317V,E255K,E255V']",['Bosutinib'],B-Lymphoblastic Leukemia/Lymphoma
74,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['Y253H,F359V,F359C,F317I,F317C,F359I,T315A,F317V,E255K,E255V']",['Bosutinib'],Chronic Myelogenous Leukemia
75,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['Y253H,F359V,F359C,F359I,E255K,E255V']",['Dasatinib'],B-Lymphoblastic Leukemia/Lymphoma
76,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['Y253H,F359V,F359C,F359I,E255K,E255V']",['Dasatinib'],Chronic Myelogenous Leukemia
77,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L1196M'],['Lorlatinib'],Non-Small Cell Lung Cancer
78,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['Lorlatinib'],Non-Small Cell Lung Cancer
79,Pilocytic Astrocytoma,Pilocytic Astrocytoma,['V600E'],['Selumetinib'],Pilocytic Astrocytoma
80,Hairy Cell Leukemia,Hairy Cell Leukemia,['V600E'],['Vemurafenib'],Hairy Cell Leukemia
81,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['V600'],['Vemurafenib'],Langerhans Cell Histiocytosis
82,Diffuse Glioma,Diffuse Glioma,['V600E'],"['Vemurafenib,Cobimetinib']",Diffuse Glioma
83,Encapsulated Glioma,Encapsulated Glioma,['V600E'],"['Vemurafenib,Cobimetinib']",Encapsulated Glioma
84,Pleomorphic Xanthoastrocytoma,Pleomorphic Xanthoastrocytoma,['V600E'],"['Vemurafenib,Cobimetinib']",Pleomorphic Xanthoastrocytoma
85,Pilocytic Astrocytoma,Pilocytic Astrocytoma,['V600E'],"['Vemurafenib,Cobimetinib']",Pilocytic Astrocytoma
86,Ganglioglioma,Ganglioglioma,['V600E'],"['Vemurafenib,Cobimetinib']",Ganglioglioma
87,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['V600'],['Dabrafenib'],Langerhans Cell Histiocytosis
88,Colorectal Cancer,Colorectal Cancer,['V600E'],"['Encorafenib,Panitumumab']",Colorectal Cancer
89,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Erdheim-Chester Disease
90,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Langerhans Cell Histiocytosis
91,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Rosai-Dorfman Disease
92,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Erdheim-Chester Disease
93,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Langerhans Cell Histiocytosis
94,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Rosai-Dorfman Disease
95,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],"['Amivantamab,Chemotherapy']",Non-Small Cell Lung Cancer
96,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],['Erlotinib'],Non-Small Cell Lung Cancer
97,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],['Osimertinib'],Non-Small Cell Lung Cancer
98,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],['Gefitinib'],Non-Small Cell Lung Cancer
99,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],['Dacomitinib'],Non-Small Cell Lung Cancer
100,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['A763_Y764insFQEA'],['Erlotinib'],Non-Small Cell Lung Cancer
101,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],"['Amivantamab,Chemotherapy']",Non-Small Cell Lung Cancer
102,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],['Dacomitinib'],Non-Small Cell Lung Cancer
103,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],['Osimertinib'],Non-Small Cell Lung Cancer
104,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],['Erlotinib'],Non-Small Cell Lung Cancer
105,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],['Gefitinib'],Non-Small Cell Lung Cancer
106,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],['Dacomitinib'],Non-Small Cell Lung Cancer
107,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],['Erlotinib'],Non-Small Cell Lung Cancer
108,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],['Osimertinib'],Non-Small Cell Lung Cancer
109,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],['Gefitinib'],Non-Small Cell Lung Cancer
110,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],"['Amivantamab,Chemotherapy']",Non-Small Cell Lung Cancer
111,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Ado-Trastuzumab Emtansine'],Non-Small Cell Lung Cancer
112,Cervical Cancer,Cervical Cancer,['Oncogenic Mutations'],['Neratinib'],Cervical Cancer
113,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],"['Neratinib,Trastuzumab,Fulvestrant']",Breast Cancer
114,Breast Cancer,Breast Cancer,['V422del'],['Elacestrant'],Breast Cancer
115,Bladder Cancer,Bladder Cancer,['Oncogenic Mutations'],['Erdafitinib'],Bladder Cancer
116,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Erdafitinib'],Non-Small Cell Lung Cancer
117,Chondrosarcoma,Chondrosarcoma,['Oncogenic Mutations'],['Ivosidenib'],Chondrosarcoma
118,Oligodendroglioma,Oligodendroglioma,['Oncogenic Mutations'],['Ivosidenib'],Oligodendroglioma
119,Astrocytoma,Astrocytoma,['Oncogenic Mutations'],['Ivosidenib'],Astrocytoma
120,Melanoma,Melanoma,"['V654A,K642E,V560D,V560G,V560del,Y553_K558del,P577del,L576P,W557G,L576del,W557R,D579del,V559A']",['Imatinib'],Melanoma
121,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,"['C809G,A829P,D816,D820,N822,Y823D']",['Sorafenib'],Gastrointestinal Stromal Tumor
122,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations'],['Cobimetinib'],Erdheim-Chester Disease
123,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations'],['Cobimetinib'],Langerhans Cell Histiocytosis
124,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations'],['Cobimetinib'],Rosai-Dorfman Disease
125,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations'],['Trametinib'],Erdheim-Chester Disease
126,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations'],['Trametinib'],Langerhans Cell Histiocytosis
127,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations'],['Trametinib'],Rosai-Dorfman Disease
128,Hepatobiliary Cancer,Hepatobiliary Cancer,['G12C'],['Adagrasib'],Hepatobiliary Cancer
129,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['G12C'],['Adagrasib'],Pancreatic Adenocarcinoma
130,Small Bowel Cancer,Small Bowel Cancer,['G12C'],['Adagrasib'],Small Bowel Cancer
131,Colorectal Cancer,Colorectal Cancer,['G12C'],"['Adagrasib,Panitumumab']",Colorectal Cancer
132,Ampullary Cancer,Ampullary Cancer,['G12C'],['Sotorasib'],Ampullary Cancer
133,Ampullary Cancer,Ampullary Cancer,['G12C'],['Adagrasib'],Ampullary Cancer
134,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['G12C'],['Sotorasib'],Pancreatic Adenocarcinoma
135,Small Bowel Cancer,Small Bowel Cancer,['G12C'],['Sotorasib'],Small Bowel Cancer
136,Colorectal Cancer,Colorectal Cancer,['G12C'],"['Sotorasib,Cetuximab']",Colorectal Cancer
137,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['Exon 14 in-frame deletions,Exon 14 Deletion,D1010,Exon 14 splice mutations']",['Crizotinib'],Non-Small Cell Lung Cancer
138,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D842V'],['Dasatinib'],Gastrointestinal Stromal Tumor
139,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Imatinib'],Gastrointestinal Stromal Tumor
140,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Sunitinib'],Gastrointestinal Stromal Tumor
141,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Regorafenib'],Gastrointestinal Stromal Tumor
142,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Ripretinib'],Gastrointestinal Stromal Tumor
143,Breast Cancer,Breast Cancer,"['Oncogenic Mutations (excluding C420R, E542K, E545A, E545D, E545G, E545K, Q546E, Q546R, H1047L, H1047R and H1047Y)']","['Alpelisib,Fulvestrant']",Breast Cancer
144,Colorectal Cancer,Colorectal Cancer,"['D402N,L474P,S478N,E318K']",['Dostarlimab'],Colorectal Cancer
145,Small Bowel Cancer,Small Bowel Cancer,"['D402N,L474P,S478N,E318K']",['Dostarlimab'],Small Bowel Cancer
146,Colorectal Cancer,Colorectal Cancer,"['D402N,L474P,S478N,E318K']","['Ipilimumab,Nivolumab']",Colorectal Cancer
147,Small Bowel Cancer,Small Bowel Cancer,"['D402N,L474P,S478N,E318K']","['Ipilimumab,Nivolumab']",Small Bowel Cancer
148,Colorectal Cancer,Colorectal Cancer,"['D402N,L474P,S478N,E318K']",['Nivolumab'],Colorectal Cancer
149,Small Bowel Cancer,Small Bowel Cancer,"['D402N,L474P,S478N,E318K']",['Nivolumab'],Small Bowel Cancer
150,Colorectal Cancer,Colorectal Cancer,"['D402N,L474P,S478N,E318K']",['Pembrolizumab'],Colorectal Cancer
151,Small Bowel Cancer,Small Bowel Cancer,"['D402N,L474P,S478N,E318K']",['Pembrolizumab'],Small Bowel Cancer
152,Colorectal Cancer,Colorectal Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Dostarlimab'],Colorectal Cancer
153,Small Bowel Cancer,Small Bowel Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Dostarlimab'],Small Bowel Cancer
154,Colorectal Cancer,Colorectal Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']","['Ipilimumab,Nivolumab']",Colorectal Cancer
155,Small Bowel Cancer,Small Bowel Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']","['Ipilimumab,Nivolumab']",Small Bowel Cancer
156,Colorectal Cancer,Colorectal Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Nivolumab'],Colorectal Cancer
157,Small Bowel Cancer,Small Bowel Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Nivolumab'],Small Bowel Cancer
158,Colorectal Cancer,Colorectal Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Pembrolizumab'],Colorectal Cancer
159,Small Bowel Cancer,Small Bowel Cancer,"['D368N,D275V,D275G,D275A,A463V,A463T,A463D,A288V,S461L,K425R,V464A,V411L,P286R,P286S,P286H,S459F,L424V,L424I,F367S,S297F,S297Y,A456P,P436R,M295R,V411M,M444K,D368Y,F367V,S459Y,P286L,Y458H,Y458C,S461T,S461P,P436S,P436H,F367L']",['Pembrolizumab'],Small Bowel Cancer
160,Ovarian Cancer,Ovarian Cancer,['E17K'],['Capivasertib'],Ovarian Cancer
161,Endometrial Cancer,Endometrial Cancer,['E17K'],['Capivasertib'],Endometrial Cancer
162,Neuroblastoma,Neuroblastoma,['F1245V'],['Lorlatinib'],Neuroblastoma
163,Neuroblastoma,Neuroblastoma,['F1174L'],['Lorlatinib'],Neuroblastoma
164,Neuroblastoma,Neuroblastoma,['R1275Q'],['Lorlatinib'],Neuroblastoma
165,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['NVL-655'],Non-Small Cell Lung Cancer
166,Neuroblastoma,Neuroblastoma,['R1275L'],['Lorlatinib'],Neuroblastoma
167,Neuroblastoma,Neuroblastoma,['F1174C'],['Lorlatinib'],Neuroblastoma
168,Neuroblastoma,Neuroblastoma,['F1245Y'],['Lorlatinib'],Neuroblastoma
169,Histiocytosis,Histiocytosis,['V600'],['Vemurafenib'],Histiocytosis
170,Histiocytosis,Histiocytosis,['V600'],['Dabrafenib'],Histiocytosis
171,Histiocytosis,Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Histiocytosis
172,Histiocytosis,Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Histiocytosis
173,Melanoma,Melanoma,['K601'],['Trametinib'],Melanoma
174,Melanoma,Melanoma,['L597'],['Trametinib'],Melanoma
175,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['L861Q,Exon 19 in-frame deletions,Exon 19 in-frame insertions,L858R,S768I,G719']",['Patritumab Deruxtecan'],Non-Small Cell Lung Cancer
176,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['S768I'],"['Amivantamab,Lazertinib']",Non-Small Cell Lung Cancer
177,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Exon 20 in-frame insertions'],['Poziotinib'],Non-Small Cell Lung Cancer
178,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Exon 20 in-frame insertions'],['Zipalertinib'],Non-Small Cell Lung Cancer
179,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L718Q'],['Afatinib'],Non-Small Cell Lung Cancer
180,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G719'],"['Amivantamab,Lazertinib']",Non-Small Cell Lung Cancer
181,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['E709_T710delinsD'],['Afatinib'],Non-Small Cell Lung Cancer
182,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G724S'],['Afatinib'],Non-Small Cell Lung Cancer
183,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L718V'],['Afatinib'],Non-Small Cell Lung Cancer
184,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L861Q'],"['Amivantamab,Lazertinib']",Non-Small Cell Lung Cancer
185,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],['Neratinib'],Breast Cancer
186,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Neratinib'],Non-Small Cell Lung Cancer
187,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Zongertinib'],Non-Small Cell Lung Cancer
188,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Sevabertinib'],Non-Small Cell Lung Cancer
189,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],"['Trastuzumab,Pertuzumab,Docetaxel']",Non-Small Cell Lung Cancer
190,Breast Cancer,Breast Cancer,['Oncogenic Mutations (excluding Fusions)'],['Fulvestrant'],Breast Cancer
191,Glioma,Glioma,['R132'],['Ivosidenib'],Glioma
192,Histiocytosis,Histiocytosis,['Oncogenic Mutations'],['Cobimetinib'],Histiocytosis
193,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['G12A,G12D,G12R,G12S,G12V']",['Daraxonrasib'],Non-Small Cell Lung Cancer
194,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,"['G12A,G12D,G12R,G12S,G12V']",['Daraxonrasib'],Pancreatic Adenocarcinoma
195,Histiocytosis,Histiocytosis,['Oncogenic Mutations'],['Trametinib'],Histiocytosis
196,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G12D'],['ASP3082'],Non-Small Cell Lung Cancer
197,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['G12D'],['ASP3082'],Pancreatic Adenocarcinoma
198,Tubular Adenoma of the Colon,Tubular Adenoma of the Colon,['G12C'],['Adagrasib'],Tubular Adenoma of the Colon
199,Esophagogastric Cancer,Esophagogastric Cancer,['G12C'],['Adagrasib'],Esophagogastric Cancer
200,Anal Cancer,Anal Cancer,['G12C'],['Adagrasib'],Anal Cancer
201,Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach,Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach,['G12C'],['Adagrasib'],Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach
202,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['H1094Y'],['Elzovantinib'],Non-Small Cell Lung Cancer
203,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Y1003'],['Tepotinib'],Non-Small Cell Lung Cancer
204,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Y1003'],['Capmatinib'],Non-Small Cell Lung Cancer
205,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Y1003'],['Crizotinib'],Non-Small Cell Lung Cancer
206,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['F1200I'],['Elzovantinib'],Non-Small Cell Lung Cancer
207,Renal Cell Carcinoma,Renal Cell Carcinoma,"['L2427Q,L2209V']",['Temsirolimus'],Renal Cell Carcinoma
208,Bladder Cancer,Bladder Cancer,"['E2014K,E2419K']",['Everolimus'],Bladder Cancer
209,Renal Cell Carcinoma,Renal Cell Carcinoma,['Q2223K'],['Everolimus'],Renal Cell Carcinoma
210,All Solid Tumors,All Solid Tumors,['G595R'],['Selitrectinib'],All Solid Tumors
211,All Solid Tumors,All Solid Tumors,['G623R'],['Selitrectinib'],All Solid Tumors
212,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G2032R'],['Taletrectinib'],Non-Small Cell Lung Cancer
213,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L2086F'],['Cabozantinib'],Non-Small Cell Lung Cancer
214,All Solid Tumors,All Solid Tumors,['Y220C'],['Rezatapopt'],All Solid Tumors
215,All Solid Tumors,All Solid Tumors,"['G469A,G469R,G469V,G464']",['Plixorafenib'],All Solid Tumors
216,All Solid Tumors,All Solid Tumors,['K601'],['Plixorafenib'],All Solid Tumors
217,All Solid Tumors,All Solid Tumors,['L597'],['Plixorafenib'],All Solid Tumors
218,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L747P'],['Afatinib'],Non-Small Cell Lung Cancer
219,Glioma,Glioma,"['R108K,T263P,A289V']",['Lapatinib'],Glioma
220,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['A763_Y764insFQEA'],['Afatinib'],Non-Small Cell Lung Cancer
221,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['D761Y'],['Osimertinib'],Non-Small Cell Lung Cancer
222,Hepatobiliary Cancer,Hepatobiliary Cancer,['Oncogenic Mutations'],['Neratinib'],Hepatobiliary Cancer
223,Biliary Tract,Biliary Tract,['Oncogenic Mutations'],['Neratinib'],Biliary Tract
224,Hepatobiliary Cancer,Hepatobiliary Cancer,['Oncogenic Mutations'],['Trastuzumab Deruxtecan'],Hepatobiliary Cancer
225,Biliary Tract,Biliary Tract,['Oncogenic Mutations'],['Trastuzumab Deruxtecan'],Biliary Tract
226,Hepatobiliary Cancer,Hepatobiliary Cancer,['Oncogenic Mutations'],"['Pertuzumab,Trastuzumab']",Hepatobiliary Cancer
227,Biliary Tract,Biliary Tract,['Oncogenic Mutations'],"['Pertuzumab,Trastuzumab']",Biliary Tract
228,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Erdafitinib'],All Solid Tumors
229,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Fexagratinib'],All Solid Tumors
230,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,"['C809G,A829P,D816,D820,N822,Y823D']",['Nilotinib'],Gastrointestinal Stromal Tumor
231,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,"['C809G,A829P,D816,D820,N822,Y823D']",['Pazopanib'],Gastrointestinal Stromal Tumor
232,All Solid Tumors,All Solid Tumors,"['G12A,G12D,G12R,G12S,G12V']",['Daraxonrasib'],All Solid Tumors
233,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Trametinib'],All Solid Tumors
234,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Cobimetinib'],All Solid Tumors
235,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Binimetinib'],All Solid Tumors
236,All Solid Tumors,All Solid Tumors,['G12D'],['MRTX-1133'],All Solid Tumors
237,All Solid Tumors,All Solid Tumors,['G12D'],['ASP3082'],All Solid Tumors
238,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['H1106D,R1170Q,N1100S,M1250T,V1092I']",['Elzovantinib'],Non-Small Cell Lung Cancer
239,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['H1106D,R1170Q,N1100S,M1250T,V1092I']",['Capmatinib'],Non-Small Cell Lung Cancer
240,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,"['H1106D,R1170Q,N1100S,M1250T,V1092I']",['Tepotinib'],Non-Small Cell Lung Cancer
241,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Everolimus'],All Solid Tumors
242,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Temsirolimus'],All Solid Tumors
243,All Solid Tumors,All Solid Tumors,['G595R'],['Zurletrectinib'],All Solid Tumors
244,All Solid Tumors,All Solid Tumors,['G623R'],['Zurletrectinib'],All Solid Tumors
245,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['RLY-2608'],All Solid Tumors
246,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],"['RLY-2608,Fulvestrant']",Breast Cancer
247,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['T315I'],['Imatinib'],B-Lymphoblastic Leukemia/Lymphoma
248,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Imatinib'],Chronic Myelogenous Leukemia
249,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['T315I'],['Dasatinib'],B-Lymphoblastic Leukemia/Lymphoma
250,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Dasatinib'],Chronic Myelogenous Leukemia
251,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['T315I'],['Nilotinib'],B-Lymphoblastic Leukemia/Lymphoma
252,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Nilotinib'],Chronic Myelogenous Leukemia
253,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['T315I'],['Bosutinib'],B-Lymphoblastic Leukemia/Lymphoma
254,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['T315I'],['Bosutinib'],Chronic Myelogenous Leukemia
255,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['V299L,F317L,G250E']",['Bosutinib'],B-Lymphoblastic Leukemia/Lymphoma
256,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['V299L,F317L,G250E']",['Bosutinib'],Chronic Myelogenous Leukemia
257,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['V299L,F317L,F317I,F317C,T315A,F317V']",['Dasatinib'],B-Lymphoblastic Leukemia/Lymphoma
258,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['V299L,F317L,F317I,F317C,T315A,F317V']",['Dasatinib'],Chronic Myelogenous Leukemia
259,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['V299L,Y253H,F359C,F317I,F317C,F359I,T315A,F317V,E255K,E255V,F317L,F359V,G250E']",['Imatinib'],B-Lymphoblastic Leukemia/Lymphoma
260,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['V299L,Y253H,F359C,F317I,F317C,F359I,T315A,F317V,E255K,E255V,F317L,F359V,G250E']",['Imatinib'],Chronic Myelogenous Leukemia
261,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,"['Y253H,F359V,G250E,F359C,F359I,E255K,E255V']",['Nilotinib'],B-Lymphoblastic Leukemia/Lymphoma
262,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,"['Y253H,F359V,G250E,F359C,F359I,E255K,E255V']",['Nilotinib'],Chronic Myelogenous Leukemia
263,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['C481S'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
264,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['T790M'],['Erlotinib'],Non-Small Cell Lung Cancer
265,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['T790M'],['Gefitinib'],Non-Small Cell Lung Cancer
266,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['T790M'],['Afatinib'],Non-Small Cell Lung Cancer
267,Colorectal Cancer,Colorectal Cancer,['Oncogenic Mutations'],['Cetuximab'],Colorectal Cancer
268,Colorectal Cancer,Colorectal Cancer,['Oncogenic Mutations'],['Panitumumab'],Colorectal Cancer
269,Colorectal Cancer,Colorectal Cancer,['Oncogenic Mutations'],"['Tucatinib,Trastuzumab']",Colorectal Cancer
270,All Solid Tumors,All Solid Tumors,['G595R'],['Larotrectinib'],All Solid Tumors
271,All Solid Tumors,All Solid Tumors,['G623R'],['Larotrectinib'],All Solid Tumors
272,All Solid Tumors,All Solid Tumors,['G696A'],['Larotrectinib'],All Solid Tumors
273,All Solid Tumors,All Solid Tumors,['F617L'],['Larotrectinib'],All Solid Tumors
274,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D842V'],['Imatinib'],Gastrointestinal Stromal Tumor
275,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1269A'],['Crizotinib'],Non-Small Cell Lung Cancer
276,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L1196M'],['Crizotinib'],Non-Small Cell Lung Cancer
277,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['C1156Y'],['Crizotinib'],Non-Small Cell Lung Cancer
278,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['I1171N'],['Alectinib'],Non-Small Cell Lung Cancer
279,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['Alectinib'],Non-Small Cell Lung Cancer
280,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['Crizotinib'],Non-Small Cell Lung Cancer
281,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['Ceritinib'],Non-Small Cell Lung Cancer
282,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G1202R'],['Brigatinib'],Non-Small Cell Lung Cancer
283,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['T474S'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
284,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['T316A'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
285,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['C481F'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
286,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['C481R'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
287,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['C481Y'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
288,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,['T474I'],['Ibrutinib'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
289,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['C797G'],['Osimertinib'],Non-Small Cell Lung Cancer
290,Colorectal Cancer,Colorectal Cancer,['G465R'],['Cetuximab'],Colorectal Cancer
291,Colorectal Cancer,Colorectal Cancer,['G465R'],['Panitumumab'],Colorectal Cancer
292,Colorectal Cancer,Colorectal Cancer,['G465E'],['Cetuximab'],Colorectal Cancer
293,Colorectal Cancer,Colorectal Cancer,['G465E'],['Panitumumab'],Colorectal Cancer
294,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['C797S'],['Osimertinib'],Non-Small Cell Lung Cancer
295,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L792F'],['Osimertinib'],Non-Small Cell Lung Cancer
296,Colorectal Cancer,Colorectal Cancer,['V441D'],['Cetuximab'],Colorectal Cancer
297,Colorectal Cancer,Colorectal Cancer,['V441D'],['Panitumumab'],Colorectal Cancer
298,Colorectal Cancer,Colorectal Cancer,['V441G'],['Cetuximab'],Colorectal Cancer
299,Colorectal Cancer,Colorectal Cancer,['V441G'],['Panitumumab'],Colorectal Cancer
300,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L718Q'],['Osimertinib'],Non-Small Cell Lung Cancer
301,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G724S'],['Osimertinib'],Non-Small Cell Lung Cancer
302,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['D761Y'],['Gefitinib'],Non-Small Cell Lung Cancer
303,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L718V'],['Osimertinib'],Non-Small Cell Lung Cancer
304,Colorectal Cancer,Colorectal Cancer,['S464L'],['Cetuximab'],Colorectal Cancer
305,Colorectal Cancer,Colorectal Cancer,['S464L'],['Panitumumab'],Colorectal Cancer
306,Colorectal Cancer,Colorectal Cancer,['S492R'],['Cetuximab'],Colorectal Cancer
307,Colorectal Cancer,Colorectal Cancer,['S492R'],['Panitumumab'],Colorectal Cancer
308,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L792H'],['Osimertinib'],Non-Small Cell Lung Cancer
309,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D820'],['Imatinib'],Gastrointestinal Stromal Tumor
310,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D820'],['Sunitinib'],Gastrointestinal Stromal Tumor
311,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Y823D'],['Imatinib'],Gastrointestinal Stromal Tumor
312,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Y823D'],['Sunitinib'],Gastrointestinal Stromal Tumor
313,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['N822'],['Imatinib'],Gastrointestinal Stromal Tumor
314,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['N822'],['Sunitinib'],Gastrointestinal Stromal Tumor
315,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['C809G'],['Imatinib'],Gastrointestinal Stromal Tumor
316,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['C809G'],['Sunitinib'],Gastrointestinal Stromal Tumor
317,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['V654A'],['Imatinib'],Gastrointestinal Stromal Tumor
318,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D816'],['Imatinib'],Gastrointestinal Stromal Tumor
319,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['D816'],['Sunitinib'],Gastrointestinal Stromal Tumor
320,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['T670I'],['Imatinib'],Gastrointestinal Stromal Tumor
321,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['A829P'],['Imatinib'],Gastrointestinal Stromal Tumor
322,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['A829P'],['Sunitinib'],Gastrointestinal Stromal Tumor
323,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['D1228N'],['Crizotinib'],Non-Small Cell Lung Cancer
324,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['D1228N'],['Cabozantinib'],Non-Small Cell Lung Cancer
325,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['D1228N'],['Capmatinib'],Non-Small Cell Lung Cancer
326,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Y1230H'],['Crizotinib'],Non-Small Cell Lung Cancer
327,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Y1230H'],['Capmatinib'],Non-Small Cell Lung Cancer
328,All Solid Tumors,All Solid Tumors,['G595R'],['Entrectinib'],All Solid Tumors
329,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G2032R'],['Crizotinib'],Non-Small Cell Lung Cancer
330,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['G2032R'],['Lorlatinib'],Non-Small Cell Lung Cancer
331,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L2086F'],['Lorlatinib'],Non-Small Cell Lung Cancer
332,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['L2086F'],['Repotrectinib'],Non-Small Cell Lung Cancer
333,Anaplastic Large-Cell Lymphoma ALK Positive,Anaplastic Large-Cell Lymphoma ALK Positive,['Fusions'],['Crizotinib'],Anaplastic Large-Cell Lymphoma ALK Positive
334,Inflammatory Myofibroblastic Tumor,Inflammatory Myofibroblastic Tumor,['Fusions'],['Crizotinib'],Inflammatory Myofibroblastic Tumor
335,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Crizotinib'],Non-Small Cell Lung Cancer
336,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Ceritinib'],Non-Small Cell Lung Cancer
337,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Ensartinib'],Non-Small Cell Lung Cancer
338,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Alectinib'],Non-Small Cell Lung Cancer
339,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Brigatinib'],Non-Small Cell Lung Cancer
340,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Lorlatinib'],Non-Small Cell Lung Cancer
341,"Low-Grade Glioma, NOS","Low-Grade Glioma, NOS",['Fusions'],['Tovorafenib'],"Low-Grade Glioma, NOS"
342,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,['Fusions'],['Pemigatinib'],Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2
343,Cholangiocarcinoma,Cholangiocarcinoma,['Fusions'],['Pemigatinib'],Cholangiocarcinoma
344,Cholangiocarcinoma,Cholangiocarcinoma,['Fusions'],['Futibatinib'],Cholangiocarcinoma
345,Acute Leukemias of Ambiguous Lineage,Acute Leukemias of Ambiguous Lineage,['Fusions'],['Revumenib'],Acute Leukemias of Ambiguous Lineage
346,Acute Myeloid Leukemia,Acute Myeloid Leukemia,['Fusions'],['Revumenib'],Acute Myeloid Leukemia
347,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['Fusions'],['Revumenib'],B-Lymphoblastic Leukemia/Lymphoma
348,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Zenocutuzumab'],Non-Small Cell Lung Cancer
349,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Fusions'],['Zenocutuzumab'],Pancreatic Adenocarcinoma
350,All Solid Tumors,All Solid Tumors,['Fusions'],['Larotrectinib'],All Solid Tumors
351,All Solid Tumors,All Solid Tumors,['Fusions'],['Repotrectinib'],All Solid Tumors
352,All Solid Tumors,All Solid Tumors,['Fusions'],['Entrectinib'],All Solid Tumors
353,All Solid Tumors,All Solid Tumors,['Fusions'],['Larotrectinib'],All Solid Tumors
354,All Solid Tumors,All Solid Tumors,['Fusions'],['Entrectinib'],All Solid Tumors
355,Myelodysplastic/Myeloproliferative Neoplasms,Myelodysplastic/Myeloproliferative Neoplasms,['Fusions'],['Imatinib'],Myelodysplastic/Myeloproliferative Neoplasms
356,Myelodysplastic/Myeloproliferative Neoplasms,Myelodysplastic/Myeloproliferative Neoplasms,['Fusions'],['Imatinib'],Myelodysplastic/Myeloproliferative Neoplasms
357,All Solid Tumors,All Solid Tumors,['Fusions'],['Selpercatinib'],All Solid Tumors
358,Medullary Thyroid Cancer,Medullary Thyroid Cancer,['Oncogenic Mutations'],['Selpercatinib'],Medullary Thyroid Cancer
359,Thyroid Cancer,Thyroid Cancer,['Fusions'],['Selpercatinib'],Thyroid Cancer
360,Thyroid Cancer,Thyroid Cancer,['Fusions'],['Pralsetinib'],Thyroid Cancer
361,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Selpercatinib'],Non-Small Cell Lung Cancer
362,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Pralsetinib'],Non-Small Cell Lung Cancer
363,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Crizotinib'],Non-Small Cell Lung Cancer
364,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Taletrectinib'],Non-Small Cell Lung Cancer
365,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Entrectinib'],Non-Small Cell Lung Cancer
366,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Repotrectinib'],Non-Small Cell Lung Cancer
367,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['BCR-ABL1 Fusion'],['Imatinib'],B-Lymphoblastic Leukemia/Lymphoma
368,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['BCR-ABL1 Fusion'],['Imatinib'],Chronic Myelogenous Leukemia
369,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['BCR-ABL1 Fusion'],['Dasatinib'],B-Lymphoblastic Leukemia/Lymphoma
370,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['BCR-ABL1 Fusion'],['Nilotinib'],Chronic Myelogenous Leukemia
371,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['BCR-ABL1 Fusion'],['Dasatinib'],Chronic Myelogenous Leukemia
372,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['BCR-ABL1 Fusion'],['Bosutinib'],Chronic Myelogenous Leukemia
373,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,['BCR-ABL1 Fusion'],['Asciminib'],Chronic Myelogenous Leukemia
374,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['BCR-ABL1 Fusion'],['Ponatinib'],B-Lymphoblastic Leukemia/Lymphoma
375,Dermatofibrosarcoma Protuberans,Dermatofibrosarcoma Protuberans,['COL1A1-PDGFB Fusion'],['Imatinib'],Dermatofibrosarcoma Protuberans
376,APL with PML-RARA,APL with PML-RARA,['PML-RARA Fusion'],['Tretinoin'],APL with PML-RARA
377,APL with PML-RARA,APL with PML-RARA,['PML-RARA Fusion'],['Arsenic Trioxide'],APL with PML-RARA
378,APL with PML-RARA,APL with PML-RARA,['PML-RARA Fusion'],"['Tretinoin,Arsenic Trioxide']",APL with PML-RARA
379,APL with PML-RARA,APL with PML-RARA,['PML-RARA Fusion'],['Arsenic Trioxide'],APL with PML-RARA
380,Inflammatory Myofibroblastic Tumor,Inflammatory Myofibroblastic Tumor,['Fusions'],['Ceritinib'],Inflammatory Myofibroblastic Tumor
381,Inflammatory Myofibroblastic Tumor,Inflammatory Myofibroblastic Tumor,['Fusions'],['Brigatinib'],Inflammatory Myofibroblastic Tumor
382,Inflammatory Myofibroblastic Tumor,Inflammatory Myofibroblastic Tumor,['Fusions'],['Lorlatinib'],Inflammatory Myofibroblastic Tumor
383,Inflammatory Myofibroblastic Tumor,Inflammatory Myofibroblastic Tumor,['Fusions'],['Alectinib'],Inflammatory Myofibroblastic Tumor
384,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Erdheim-Chester Disease
385,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Langerhans Cell Histiocytosis
386,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Rosai-Dorfman Disease
387,Pilocytic Astrocytoma,Pilocytic Astrocytoma,['Fusions'],['Selumetinib'],Pilocytic Astrocytoma
388,Erdheim-Chester Disease,Erdheim-Chester Disease,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Erdheim-Chester Disease
389,Langerhans Cell Histiocytosis,Langerhans Cell Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Langerhans Cell Histiocytosis
390,Rosai-Dorfman Disease,Rosai-Dorfman Disease,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Rosai-Dorfman Disease
391,Pancreatic Cancer,Pancreatic Cancer,['Fusions'],['Erdafitinib'],Pancreatic Cancer
392,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['Erdafitinib'],Non-Small Cell Lung Cancer
393,Bladder Cancer,Bladder Cancer,['Oncogenic Mutations'],['Erdafitinib'],Bladder Cancer
394,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,['Fusions'],['Ruxolitinib'],Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2
395,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2,['Fusions'],['Fedratinib'],Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2
396,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Imatinib'],Gastrointestinal Stromal Tumor
397,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Sunitinib'],Gastrointestinal Stromal Tumor
398,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Regorafenib'],Gastrointestinal Stromal Tumor
399,Gastrointestinal Stromal Tumor,Gastrointestinal Stromal Tumor,['Oncogenic Mutations'],['Ripretinib'],Gastrointestinal Stromal Tumor
400,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Cabozantinib'],Non-Small Cell Lung Cancer
401,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Ceritinib'],Non-Small Cell Lung Cancer
402,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Lorlatinib'],Non-Small Cell Lung Cancer
403,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['BCR-ABL1 Fusion'],['Bosutinib'],B-Lymphoblastic Leukemia/Lymphoma
404,B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma,['BCR-ABL1 Fusion'],['Nilotinib'],B-Lymphoblastic Leukemia/Lymphoma
405,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['NVL-655'],Non-Small Cell Lung Cancer
406,Histiocytosis,Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Cobimetinib'],Histiocytosis
407,Melanoma,Melanoma,['Fusions'],['Trametinib'],Melanoma
408,Ovarian Cancer,Ovarian Cancer,['Fusions'],['Trametinib'],Ovarian Cancer
409,Melanoma,Melanoma,['Fusions'],['Cobimetinib'],Melanoma
410,Ovarian Cancer,Ovarian Cancer,['Fusions'],['Cobimetinib'],Ovarian Cancer
411,Histiocytosis,Histiocytosis,['Oncogenic Mutations (excluding V600)'],['Trametinib'],Histiocytosis
412,Cholangiocarcinoma,Cholangiocarcinoma,['Oncogenic Mutations'],['Lirafugratinib'],Cholangiocarcinoma
413,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Seribantumab'],Non-Small Cell Lung Cancer
414,All Solid Tumors,All Solid Tumors,['Fusions'],['Zenocutuzumab'],All Solid Tumors
415,Medullary Thyroid Cancer,Medullary Thyroid Cancer,['Oncogenic Mutations'],['Pralsetinib'],Medullary Thyroid Cancer
416,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Fusions'],['Vandetanib'],Non-Small Cell Lung Cancer
417,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Erdafitinib'],All Solid Tumors
418,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Fexagratinib'],All Solid Tumors
419,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Erdafitinib'],All Solid Tumors
420,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Lirafugratinib'],All Solid Tumors
421,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Fexagratinib'],All Solid Tumors
422,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Erdafitinib'],All Solid Tumors
423,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Fexagratinib'],All Solid Tumors
424,All Solid Tumors,All Solid Tumors,['Fusions'],['Crizotinib'],All Solid Tumors
425,All Solid Tumors,All Solid Tumors,['Fusions'],['Zurletrectinib'],All Solid Tumors
426,All Solid Tumors,All Solid Tumors,['Fusions'],['Zurletrectinib'],All Solid Tumors
427,All Solid Tumors,All Solid Tumors,['Fusions'],['Zurletrectinib'],All Solid Tumors
428,Ewing Sarcoma,Ewing Sarcoma,['EWSR1-FLI1 Fusion'],['TK216'],Ewing Sarcoma
429,Ewing Sarcoma of Soft Tissue,Ewing Sarcoma of Soft Tissue,['EWSR1-FLI1 Fusion'],['TK216'],Ewing Sarcoma of Soft Tissue
430,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
431,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
432,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
433,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
434,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
435,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
436,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
437,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
438,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],['Olaparib'],Ovarian Cancer
439,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],['Olaparib'],Ovary/Fallopian Tube
440,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],['Olaparib'],Peritoneal Serous Carcinoma
441,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
442,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
443,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Ovarian Cancer
444,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Ovary/Fallopian Tube
445,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Peritoneal Serous Carcinoma
446,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Rucaparib'],"Prostate Cancer, NOS"
447,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Rucaparib'],Prostate Cancer
448,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Olaparib,Abiraterone,Prednisone']","Prostate Cancer, NOS"
449,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Olaparib,Abiraterone,Prednisone']",Prostate Cancer
450,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],['Rucaparib'],Ovarian Cancer
451,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],['Rucaparib'],Ovary/Fallopian Tube
452,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],['Rucaparib'],Peritoneal Serous Carcinoma
453,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],['Niraparib'],Ovarian Cancer
454,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],['Niraparib'],Ovary/Fallopian Tube
455,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],['Niraparib'],Peritoneal Serous Carcinoma
456,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
457,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
458,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Niraparib,Abiraterone Acetate,Prednisone']","Prostate Cancer, NOS"
459,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Niraparib,Abiraterone Acetate,Prednisone']",Prostate Cancer
460,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],['Olaparib'],Ovarian Cancer
461,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],['Olaparib'],Ovary/Fallopian Tube
462,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],['Olaparib'],Peritoneal Serous Carcinoma
463,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
464,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
465,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Ovarian Cancer
466,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Ovary/Fallopian Tube
467,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],"['Olaparib,Bevacizumab']",Peritoneal Serous Carcinoma
468,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Rucaparib'],"Prostate Cancer, NOS"
469,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Rucaparib'],Prostate Cancer
470,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Olaparib,Abiraterone,Prednisone']","Prostate Cancer, NOS"
471,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Olaparib,Abiraterone,Prednisone']",Prostate Cancer
472,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],['Rucaparib'],Ovarian Cancer
473,Ovary/Fallopian Tube,Ovary/Fallopian Tube,['Oncogenic Mutations'],['Rucaparib'],Ovary/Fallopian Tube
474,Peritoneal Serous Carcinoma,Peritoneal Serous Carcinoma,['Oncogenic Mutations'],['Rucaparib'],Peritoneal Serous Carcinoma
475,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
476,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
477,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Niraparib,Abiraterone Acetate,Prednisone']","Prostate Cancer, NOS"
478,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Niraparib,Abiraterone Acetate,Prednisone']",Prostate Cancer
479,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
480,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
481,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
482,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
483,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
484,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
485,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
486,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
487,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
488,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
489,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
490,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
491,Breast Cancer,Breast Cancer,['Amplification'],['Trastuzumab'],Breast Cancer
492,Esophagogastric Adenocarcinoma,Esophagogastric Adenocarcinoma,['Amplification'],"['Trastuzumab,Chemotherapy']",Esophagogastric Adenocarcinoma
493,Esophagogastric Adenocarcinoma,Esophagogastric Adenocarcinoma,['Amplification'],['Trastuzumab Deruxtecan'],Esophagogastric Adenocarcinoma
494,Breast Cancer,Breast Cancer,['Amplification'],"['Trastuzumab,Chemotherapy']",Breast Cancer
495,Breast Cancer,Breast Cancer,['Amplification'],['Ado-Trastuzumab Emtansine'],Breast Cancer
496,Esophagogastric Adenocarcinoma,Esophagogastric Adenocarcinoma,['Amplification'],"['Pembrolizumab,Trastuzumab,Chemotherapy']",Esophagogastric Adenocarcinoma
497,Breast Cancer,Breast Cancer,['Amplification'],"['Lapatinib,Capecitabine']",Breast Cancer
498,Colorectal Cancer,Colorectal Cancer,['Amplification'],"['Tucatinib,Trastuzumab']",Colorectal Cancer
499,Breast Cancer,Breast Cancer,['Amplification'],"['Lapatinib,Letrozole']",Breast Cancer
500,Breast Cancer,Breast Cancer,['Amplification'],"['Trastuzumab,Pertuzumab,Chemotherapy']",Breast Cancer
501,Breast Cancer,Breast Cancer,['Amplification'],['Neratinib'],Breast Cancer
502,Breast Cancer,Breast Cancer,['Amplification'],"['Neratinib,Capecitabine']",Breast Cancer
503,Breast Cancer,Breast Cancer,['Amplification'],"['Trastuzumab,Tucatinib,Capecitabine']",Breast Cancer
504,Breast Cancer,Breast Cancer,['Amplification'],['Trastuzumab Deruxtecan'],Breast Cancer
505,Breast Cancer,Breast Cancer,['Amplification'],"['Margetuximab,Chemotherapy']",Breast Cancer
506,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
507,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
508,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
509,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
510,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
511,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
512,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
513,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
514,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
515,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
516,Neurofibroma,Neurofibroma,['Oncogenic Mutations'],['Mirdametinib'],Neurofibroma
517,Neurofibroma,Neurofibroma,['Oncogenic Mutations'],['Selumetinib'],Neurofibroma
518,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
519,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
520,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
521,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
522,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],"['Capivasertib,Fulvestrant']",Breast Cancer
523,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
524,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
525,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
526,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
527,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']","Prostate Cancer, NOS"
528,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],"['Talazoparib,Enzalutamide']",Prostate Cancer
529,"Prostate Cancer, NOS","Prostate Cancer, NOS",['Oncogenic Mutations'],['Olaparib'],"Prostate Cancer, NOS"
530,Prostate Cancer,Prostate Cancer,['Oncogenic Mutations'],['Olaparib'],Prostate Cancer
531,Epithelioid Sarcoma,Epithelioid Sarcoma,['Deletion'],['Tazemetostat'],Epithelioid Sarcoma
532,Encapsulated Glioma,Encapsulated Glioma,['Oncogenic Mutations'],['Everolimus'],Encapsulated Glioma
533,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Oncogenic Mutations'],['Rucaparib'],Pancreatic Adenocarcinoma
534,Acinar Cell Carcinoma of the Pancreas,Acinar Cell Carcinoma of the Pancreas,['Oncogenic Mutations'],['Rucaparib'],Acinar Cell Carcinoma of the Pancreas
535,Uterine Sarcoma,Uterine Sarcoma,['Oncogenic Mutations'],['Olaparib'],Uterine Sarcoma
536,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Oncogenic Mutations'],['Rucaparib'],Pancreatic Adenocarcinoma
537,Acinar Cell Carcinoma of the Pancreas,Acinar Cell Carcinoma of the Pancreas,['Oncogenic Mutations'],['Rucaparib'],Acinar Cell Carcinoma of the Pancreas
538,Uterine Sarcoma,Uterine Sarcoma,['Oncogenic Mutations'],['Rucaparib'],Uterine Sarcoma
539,Uterine Sarcoma,Uterine Sarcoma,['Oncogenic Mutations'],['Niraparib'],Uterine Sarcoma
540,Salivary Gland Cancer,Salivary Gland Cancer,['Amplification'],['Trastuzumab'],Salivary Gland Cancer
541,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,['Amplification'],"['Trastuzumab,Carboplatin-Taxol Regimen']",Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma
542,Colorectal Cancer,Colorectal Cancer,['Amplification'],"['Trastuzumab,Pertuzumab']",Colorectal Cancer
543,Hepatobiliary Cancer,Hepatobiliary Cancer,['Amplification'],"['Trastuzumab,Pertuzumab']",Hepatobiliary Cancer
544,Biliary Tract,Biliary Tract,['Amplification'],"['Trastuzumab,Pertuzumab']",Biliary Tract
545,Hepatobiliary Cancer,Hepatobiliary Cancer,['Amplification'],"['Tucatinib,Trastuzumab']",Hepatobiliary Cancer
546,Biliary Tract,Biliary Tract,['Amplification'],"['Tucatinib,Trastuzumab']",Biliary Tract
547,Colorectal Cancer,Colorectal Cancer,['Amplification'],"['Lapatinib,Trastuzumab']",Colorectal Cancer
548,Salivary Gland Cancer,Salivary Gland Cancer,['Amplification'],"['Trastuzumab,Docetaxel']",Salivary Gland Cancer
549,Salivary Gland Cancer,Salivary Gland Cancer,['Amplification'],['Ado-Trastuzumab Emtansine'],Salivary Gland Cancer
550,Colorectal Cancer,Colorectal Cancer,['Amplification'],['Trastuzumab Deruxtecan'],Colorectal Cancer
551,Salivary Gland Cancer,Salivary Gland Cancer,['Amplification'],['Trastuzumab Deruxtecan'],Salivary Gland Cancer
552,Salivary Gland Cancer,Salivary Gland Cancer,['Amplification'],"['Trastuzumab,Pertuzumab']",Salivary Gland Cancer
553,Follicular Lymphoma,Follicular Lymphoma,"['Oncogenic Mutations (excluding Y646S, Y646H, Y646C, Y646F, Y646N, A682G and A692V)']",['Tazemetostat'],Follicular Lymphoma
554,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Crizotinib'],Non-Small Cell Lung Cancer
555,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Capmatinib'],Non-Small Cell Lung Cancer
556,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Tepotinib'],Non-Small Cell Lung Cancer
557,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Oncogenic Mutations'],['Rucaparib'],Pancreatic Adenocarcinoma
558,Acinar Cell Carcinoma of the Pancreas,Acinar Cell Carcinoma of the Pancreas,['Oncogenic Mutations'],['Rucaparib'],Acinar Cell Carcinoma of the Pancreas
559,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Oncogenic Mutations'],['Olaparib'],Pancreatic Adenocarcinoma
560,Acinar Cell Carcinoma of the Pancreas,Acinar Cell Carcinoma of the Pancreas,['Oncogenic Mutations'],['Olaparib'],Acinar Cell Carcinoma of the Pancreas
561,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],['Talazoparib'],Breast Cancer
562,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],['Olaparib'],Breast Cancer
563,Pancreatic Adenocarcinoma,Pancreatic Adenocarcinoma,['Oncogenic Mutations'],['Olaparib'],Pancreatic Adenocarcinoma
564,Acinar Cell Carcinoma of the Pancreas,Acinar Cell Carcinoma of the Pancreas,['Oncogenic Mutations'],['Olaparib'],Acinar Cell Carcinoma of the Pancreas
565,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],['Talazoparib'],Breast Cancer
566,Breast Cancer,Breast Cancer,['Oncogenic Mutations'],['Olaparib'],Breast Cancer
567,Ovarian Cancer,Ovarian Cancer,['Amplification'],"['Lunresertib,Camonsertib']",Ovarian Cancer
568,Endometrial Cancer,Endometrial Cancer,['Amplification'],"['Lunresertib,Camonsertib']",Endometrial Cancer
569,Esophagogastric Cancer,Esophagogastric Cancer,['Amplification'],['Cetuximab'],Esophagogastric Cancer
570,Esophagogastric Cancer,Esophagogastric Cancer,['Amplification'],"['Cetuximab,Chemotherapy']",Esophagogastric Cancer
571,Esophagogastric Cancer,Esophagogastric Cancer,['Amplification'],['Panitumumab'],Esophagogastric Cancer
572,Esophagogastric Cancer,Esophagogastric Cancer,['Amplification'],"['Panitumumab,Chemotherapy']",Esophagogastric Cancer
573,All Solid Tumors,All Solid Tumors,['Amplification'],['Trastuzumab Deruxtecan'],All Solid Tumors
574,Hepatobiliary Cancer,Hepatobiliary Cancer,['Amplification'],['Zanidatamab'],Hepatobiliary Cancer
575,Biliary Tract,Biliary Tract,['Amplification'],['Zanidatamab'],Biliary Tract
576,Bladder Cancer,Bladder Cancer,['Oncogenic Mutations'],['Cisplatin'],Bladder Cancer
577,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",Ovarian Cancer
578,Endometrial Cancer,Endometrial Cancer,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",Endometrial Cancer
579,Hepatobiliary Cancer,Hepatobiliary Cancer,['Amplification'],['Brigimadlin'],Hepatobiliary Cancer
580,Biliary Tract,Biliary Tract,['Amplification'],['Brigimadlin'],Biliary Tract
581,Intimal Sarcoma,Intimal Sarcoma,['Amplification'],['Milademetan'],Intimal Sarcoma
582,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcoma,['Amplification'],['Brigimadlin'],Dedifferentiated Liposarcoma
583,Well-Differentiated Liposarcoma,Well-Differentiated Liposarcoma,['Amplification'],['Brigimadlin'],Well-Differentiated Liposarcoma
584,Hepatobiliary Cancer,Hepatobiliary Cancer,['Amplification'],"['Brigimadlin,Ezabenlimab']",Hepatobiliary Cancer
585,Biliary Tract,Biliary Tract,['Amplification'],"['Brigimadlin,Ezabenlimab']",Biliary Tract
586,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Telisotuzumab Vedotin'],Non-Small Cell Lung Cancer
587,All Solid Tumors,All Solid Tumors,['Deletion'],['AMG 193'],All Solid Tumors
588,All Solid Tumors,All Solid Tumors,['Deletion'],['MRTX1719'],All Solid Tumors
589,Acute Myeloid Leukemia,Acute Myeloid Leukemia,['Oncogenic Mutations'],['Revumenib'],Acute Myeloid Leukemia
590,Ovarian Cancer,Ovarian Cancer,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",Ovarian Cancer
591,Endometrial Cancer,Endometrial Cancer,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",Endometrial Cancer
592,Esophageal Adenocarcinoma,Esophageal Adenocarcinoma,['Oncogenic Mutations'],['PRT3789'],Esophageal Adenocarcinoma
593,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],['PRT3789'],Non-Small Cell Lung Cancer
594,Perivascular Epithelioid Cell Tumor,Perivascular Epithelioid Cell Tumor,['Oncogenic Mutations'],['ABI-009'],Perivascular Epithelioid Cell Tumor
595,Uterine Perivascular Epithelioid Cell Tumor,Uterine Perivascular Epithelioid Cell Tumor,['Oncogenic Mutations'],['ABI-009'],Uterine Perivascular Epithelioid Cell Tumor
596,All Solid Tumors,All Solid Tumors,['Amplification'],['Lunresertib'],All Solid Tumors
597,All Solid Tumors,All Solid Tumors,['Amplification'],"['Lunresertib,Camonsertib']",All Solid Tumors
598,All Solid Tumors,All Solid Tumors,['Amplification'],['BLU-222'],All Solid Tumors
599,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcoma,['Amplification'],['Palbociclib'],Dedifferentiated Liposarcoma
600,Well-Differentiated Liposarcoma,Well-Differentiated Liposarcoma,['Amplification'],['Palbociclib'],Well-Differentiated Liposarcoma
601,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcoma,['Amplification'],['Abemaciclib'],Dedifferentiated Liposarcoma
602,Well-Differentiated Liposarcoma,Well-Differentiated Liposarcoma,['Amplification'],['Abemaciclib'],Well-Differentiated Liposarcoma
603,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Palbociclib'],All Solid Tumors
604,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Ribociclib'],All Solid Tumors
605,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Abemaciclib'],All Solid Tumors
606,Glioma,Glioma,['Amplification'],['Lapatinib'],Glioma
607,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",All Solid Tumors
608,All Solid Tumors,All Solid Tumors,['Amplification'],['Lirafugratinib'],All Solid Tumors
609,Bladder Cancer,Bladder Cancer,['Oncogenic Mutations'],['Tazemetostat'],Bladder Cancer
610,All Solid Tumors,All Solid Tumors,['Amplification'],['Brigimadlin'],All Solid Tumors
611,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcoma,['Amplification'],['Milademetan'],Dedifferentiated Liposarcoma
612,Well-Differentiated Liposarcoma,Well-Differentiated Liposarcoma,['Amplification'],['Milademetan'],Well-Differentiated Liposarcoma
613,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Trametinib'],All Solid Tumors
614,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['Cobimetinib'],All Solid Tumors
615,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],"['Lunresertib,Camonsertib']",All Solid Tumors
616,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['GSK2636771'],All Solid Tumors
617,All Solid Tumors,All Solid Tumors,['Oncogenic Mutations'],['AZD8186'],All Solid Tumors
618,All Liquid Tumors,All Liquid Tumors,['Oncogenic Mutations'],['Tazemetostat'],All Liquid Tumors
619,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Oncogenic Mutations'],"['Bemcentinib,Pembrolizumab']",Non-Small Cell Lung Cancer
620,Chronic Myelomonocytic Leukemia,Chronic Myelomonocytic Leukemia,['Oncogenic Mutations'],['Ceralasertib'],Chronic Myelomonocytic Leukemia
621,Myelodysplastic Syndromes,Myelodysplastic Syndromes,['Oncogenic Mutations'],['Ceralasertib'],Myelodysplastic Syndromes
622,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Erlotinib'],Non-Small Cell Lung Cancer
623,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Gefitinib'],Non-Small Cell Lung Cancer
624,Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,['Amplification'],['Osimertinib'],Non-Small Cell Lung Cancer
